Atherosclerosis, the pathological basis of most cardiovascular disease (CVD), is closely
associated with cholesterol accumulation in the arterial intima. Excessive cholesterol is …

For> 4 decades it has been recognized that elevated serum levels of high-density
lipoprotein cholesterol (HDL-C) are associated with reduced risk of cardiovascular disease …

BACKGROUND A growing body of evidence from epidemiological data, animal studies, and
clinical trials supports HDL as the next target to reduce residual cardiovascular risk in statin …

Atherogenic dyslipidemia comprises a triad of increased blood concentrations of small,
dense low-density lipoprotein (LDL) particles, decreased high-density lipoprotein (HDL) …

It is well recognized that high-density lipoprotein (HDL)-cholesterol is antiatherogenic and
serves a role in mediating cholesterol efflux from cells. However, HDL has multiple …

During the last several years interest has focused on the importance of the lipid‐transporting
apolipoproteins–apoB transports all potentially atherogenic very low‐density lipoprotein …

Objective—We measured efflux from macrophages to apolipoprotein B-depleted serum from
263 specimens and found instances in which serum having similar high-density lipoprotein …

ContextHigh-density lipoprotein cholesterol (HDL-C) is a cardiovascular risk factor that is
gaining substantial interest as a therapeutic target. ObjectivesTo review the current and …

We examined the association between rate of cholesterol esterification in plasma depleted
of apolipoprotein B-containing lipoproteins (FER HDL), atherogenic index of plasma …

Previous studies indicate that reduced concentrations of circulating high-density lipoprotein
(HDL) particles can be superior to HDL-cholesterol (HDL-C) levels as a predictor of …